Turkey	B:C0024794
herpesvirus	I:C0024794
with	O
an	O
insertion	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
displays	O
an	O
appropriate	O
balance	O
between	O
growth	O
activity	O
and	O
antibody	O
-	O
eliciting	O
capacity	O
and	O
is	O
suitable	O
for	O
the	O
establishment	O
of	O
a	O
recombinant	O
vaccine	I:C0034862
.	O

Turkey	O
herpesvirus	I:C0024794
with	O
an	O
insertion	B:C1955829
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
displays	O
an	O
appropriate	O
balance	O
between	O
growth	O
activity	O
and	O
antibody	O
-	O
eliciting	O
capacity	O
and	O
is	O
suitable	O
for	O
the	O
establishment	O
of	O
a	O
recombinant	O
vaccine	I:C0034862
.	O

Turkey	O
herpesvirus	I:C0024794
with	O
an	O
insertion	O
in	O
the	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
region	I:C0314659
displays	O
an	O
appropriate	O
balance	O
between	O
growth	O
activity	O
and	O
antibody	O
-	O
eliciting	O
capacity	O
and	O
is	O
suitable	O
for	O
the	O
establishment	O
of	O
a	O
recombinant	O
vaccine	I:C0034862
.	O

Turkey	O
herpesvirus	I:C0024794
with	O
an	O
insertion	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
displays	O
an	O
appropriate	O
balance	O
between	O
growth	B:C0007595
activity	O
and	O
antibody	O
-	O
eliciting	O
capacity	O
and	O
is	O
suitable	O
for	O
the	O
establishment	O
of	O
a	O
recombinant	O
vaccine	I:C0034862
.	O

Turkey	O
herpesvirus	I:C0024794
with	O
an	O
insertion	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
displays	O
an	O
appropriate	O
balance	O
between	O
growth	O
activity	O
and	O
antibody	B:C0003241
-	O
eliciting	O
capacity	O
and	O
is	O
suitable	O
for	O
the	O
establishment	O
of	O
a	O
recombinant	O
vaccine	I:C0034862
.	O

Turkey	O
herpesvirus	I:C0024794
with	O
an	O
insertion	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
displays	O
an	O
appropriate	O
balance	O
between	O
growth	O
activity	O
and	O
antibody	O
-	O
eliciting	O
capacity	O
and	O
is	O
suitable	O
for	O
the	O
establishment	O
of	O
a	O
recombinant	B:C0034862
vaccine	I:C0034862
.	O

We	O
constructed	O
turkey	B:C0024794
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	B:C0024794
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	B:C0017337
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	B:C0021338
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	B:C0021338
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	B:C0024794
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	B:C0017428
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	B:C0314659
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	B:C0314659
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	O
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
constructed	O
turkey	O
herpesvirus	I:C0024794
(	O
HVT	O
)	O
vector	O
vaccines	O
in	O
which	O
the	O
VP2	O
gene	I:C0017337
of	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
(	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
)	O
was	O
inserted	O
into	O
the	O
HVT	O
genome	O
in	O
the	O
following	O
regions	O
:	O
UL3	O
-	I:C0314659
4	I:C0314659
,	O
UL22	O
-	I:C0314659
23	I:C0314659
,	O
UL45	O
-	I:C0314659
46	I:C0314659
,	O
and	O
US10	B:C0314659
-	I:C0314659
SORF3	I:C0314659
.	O

We	O
then	O
evaluated	O
the	O
relationship	O
between	O
the	O
gene	B:C1955829
insertion	I:C1955829
site	O
and	O
the	O
capacity	O
of	O
the	O
virus	O
to	O
elicit	O
antibodies	O
.	O

We	O
then	O
evaluated	O
the	O
relationship	O
between	O
the	O
gene	O
insertion	I:C1955829
site	O
and	O
the	O
capacity	O
of	O
the	O
virus	B:C0042776
to	O
elicit	O
antibodies	O
.	O

We	O
then	O
evaluated	O
the	O
relationship	O
between	O
the	O
gene	O
insertion	I:C1955829
site	O
and	O
the	O
capacity	O
of	O
the	O
virus	O
to	O
elicit	O
antibodies	B:C0003241
.	O

rHVT	B:C0034862
/IBD	I:C0034862
(	O
US10	O
)	O
showed	O
good	O
growth	O
activity	O
in	O
vitro	I:C1515653
,	O
with	O
growth	O
comparable	O
to	O
that	O
of	O
the	O
parent	O
HVT	O
.	O

rHVT	O
/IBD	I:C0034862
(	O
US10	B:C0314659
)	O
showed	O
good	O
growth	O
activity	O
in	O
vitro	I:C1515653
,	O
with	O
growth	O
comparable	O
to	O
that	O
of	O
the	O
parent	O
HVT	O
.	O

rHVT	O
/IBD	I:C0034862
(	O
US10	O
)	O
showed	O
good	O
growth	B:C0007595
activity	O
in	O
vitro	I:C1515653
,	O
with	O
growth	O
comparable	O
to	O
that	O
of	O
the	O
parent	O
HVT	O
.	O

rHVT	O
/IBD	I:C0034862
(	O
US10	O
)	O
showed	O
good	O
growth	O
activity	O
in	B:C1515653
vitro	I:C1515653
,	O
with	O
growth	O
comparable	O
to	O
that	O
of	O
the	O
parent	O
HVT	O
.	O

rHVT	O
/IBD	I:C0034862
(	O
US10	O
)	O
showed	O
good	O
growth	O
activity	O
in	O
vitro	I:C1515653
,	O
with	O
growth	B:C0007595
comparable	O
to	O
that	O
of	O
the	O
parent	O
HVT	O
.	O

rHVT	O
/IBD	I:C0034862
(	O
US10	O
)	O
showed	O
good	O
growth	O
activity	O
in	O
vitro	I:C1515653
,	O
with	O
growth	O
comparable	O
to	O
that	O
of	O
the	O
parent	O
HVT	B:C0024794
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	B:C0314659
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	B:C0314659
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	B:C0007595
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	B:C0008046
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	B:C0016030
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	O
.	O

On	O
the	O
other	O
hand	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL22	O
-	I:C0314659
23	I:C0314659
)	O
,	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
exhibited	O
decreased	O
growth	O
activity	O
in	O
chicken	O
embryo	I:C0008046
fibroblast	O
(	I:C0016030
CEF	I:C0016030
)	I:C0016030
cells	I:C0016030
compared	O
to	O
the	O
parent	O
HVT	B:C0024794
.	O

However	O
,	O
the	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
US10	O
)	O
elicited	O
lower	O
levels	O
of	O
virus	O
-	I:C2986386
neutralizing	I:C2986386
(	I:C2986386
VN	I:C2986386
)	I:C2986386
antibodies	I:C2986386
compared	O
to	O
the	O
other	O
constructs	O
.	O

However	O
,	O
the	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
US10	B:C0314659
)	O
elicited	O
lower	O
levels	O
of	O
virus	O
-	I:C2986386
neutralizing	I:C2986386
(	I:C2986386
VN	I:C2986386
)	I:C2986386
antibodies	I:C2986386
compared	O
to	O
the	O
other	O
constructs	O
.	O

However	O
,	O
the	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
US10	O
)	O
elicited	O
lower	O
levels	O
of	O
virus	B:C2986386
-	I:C2986386
neutralizing	I:C2986386
(	I:C2986386
VN	I:C2986386
)	I:C2986386
antibodies	I:C2986386
compared	O
to	O
the	O
other	O
constructs	O
.	O

rHVT	B:C0034862
/IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
appeared	O
to	O
be	O
similar	O
in	O
their	O
ability	O
to	O
elicit	O
VN	O
antibodies	I:C2986386
.	O

rHVT	O
/IBD	I:C0034862
(	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
)	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
appeared	O
to	O
be	O
similar	O
in	O
their	O
ability	O
to	O
elicit	O
VN	O
antibodies	I:C2986386
.	O

rHVT	O
/IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
and	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
appeared	O
to	O
be	O
similar	O
in	O
their	O
ability	O
to	O
elicit	O
VN	O
antibodies	I:C2986386
.	O

rHVT	O
/IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	B:C0314659
-	I:C0314659
46	I:C0314659
)	O
appeared	O
to	O
be	O
similar	O
in	O
their	O
ability	O
to	O
elicit	O
VN	O
antibodies	I:C2986386
.	O

rHVT	O
/IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
and	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL45	O
-	I:C0314659
46	I:C0314659
)	O
appeared	O
to	O
be	O
similar	O
in	O
their	O
ability	O
to	O
elicit	O
VN	B:C2986386
antibodies	I:C2986386
.	O

Based	O
on	O
the	O
results	O
of	O
in	B:C1515653
vitro	I:C1515653
and	O
in	O
vivo	O
assays	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
was	O
selected	O
for	O
further	O
testing	O
.	O

Based	O
on	O
the	O
results	O
of	O
in	O
vitro	I:C1515653
and	O
in	O
vivo	O
assays	O
,	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
was	O
selected	O
for	O
further	O
testing	O
.	O

Based	O
on	O
the	O
results	O
of	O
in	O
vitro	I:C1515653
and	O
in	O
vivo	O
assays	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
)	O
was	O
selected	O
for	O
further	O
testing	O
.	O

In	O
a	O
challenge	O
assay	B:C0005507
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
protected	O
chickens	O
from	O
challenge	O
with	O
virulent	O
Marek	O
's	I:C0024794
disease	I:C0024794
virus	I:C0024794
serotype	I:C0024794
1	I:C0024794
and	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
.	O

In	O
a	O
challenge	O
assay	O
,	O
rHVT	B:C0034862
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
protected	O
chickens	O
from	O
challenge	O
with	O
virulent	O
Marek	O
's	I:C0024794
disease	I:C0024794
virus	I:C0024794
serotype	I:C0024794
1	I:C0024794
and	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
.	O

In	O
a	O
challenge	O
assay	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
)	O
protected	O
chickens	O
from	O
challenge	O
with	O
virulent	O
Marek	O
's	I:C0024794
disease	I:C0024794
virus	I:C0024794
serotype	I:C0024794
1	I:C0024794
and	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
.	O

In	O
a	O
challenge	O
assay	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
protected	O
chickens	B:C0008051
from	O
challenge	O
with	O
virulent	O
Marek	O
's	I:C0024794
disease	I:C0024794
virus	I:C0024794
serotype	I:C0024794
1	I:C0024794
and	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
.	O

In	O
a	O
challenge	O
assay	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
protected	O
chickens	O
from	O
challenge	O
with	O
virulent	O
Marek	B:C0024794
's	I:C0024794
disease	I:C0024794
virus	I:C0024794
serotype	I:C0024794
1	I:C0024794
and	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
.	O

In	O
a	O
challenge	O
assay	O
,	O
rHVT	O
/	I:C0034862
IBD	I:C0034862
(	O
UL3	O
-	I:C0314659
4	I:C0314659
)	O
protected	O
chickens	O
from	O
challenge	O
with	O
virulent	O
Marek	O
's	I:C0024794
disease	I:C0024794
virus	I:C0024794
serotype	I:C0024794
1	I:C0024794
and	O
infectious	B:C0021338
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
.	O

In	O
conclusion	O
,	O
the	O
site	O
of	O
gene	B:C1955829
insertion	I:C1955829
may	O
have	O
a	O
strong	O
effect	O
on	O
the	O
growth	O
of	O
the	O
vector	O
virus	O
in	O
vitro	I:C1515653
and	O
its	O
antibody	O
-	O
eliciting	O
capacity	O
.	O

In	O
conclusion	O
,	O
the	O
site	O
of	O
gene	O
insertion	I:C1955829
may	O
have	O
a	O
strong	O
effect	O
on	O
the	O
growth	B:C0007595
of	O
the	O
vector	O
virus	O
in	O
vitro	I:C1515653
and	O
its	O
antibody	O
-	O
eliciting	O
capacity	O
.	O

In	O
conclusion	O
,	O
the	O
site	O
of	O
gene	O
insertion	I:C1955829
may	O
have	O
a	O
strong	O
effect	O
on	O
the	O
growth	O
of	O
the	O
vector	O
virus	O
in	B:C1515653
vitro	I:C1515653
and	O
its	O
antibody	O
-	O
eliciting	O
capacity	O
.	O

In	O
conclusion	O
,	O
the	O
site	O
of	O
gene	O
insertion	I:C1955829
may	O
have	O
a	O
strong	O
effect	O
on	O
the	O
growth	O
of	O
the	O
vector	O
virus	O
in	O
vitro	I:C1515653
and	O
its	O
antibody	B:C0003241
-	O
eliciting	O
capacity	O
.	O

Insertions	B:C1955829
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	O
activity	O
and	O
VN	O
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	O
site	I:C0449682
for	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	O
.	O

Insertions	O
in	O
the	O
UL3	B:C0314659
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	O
activity	O
and	O
VN	O
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	O
site	I:C0449682
for	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	O
.	O

Insertions	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	B:C0007595
activity	O
and	O
VN	O
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	O
site	I:C0449682
for	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	O
.	O

Insertions	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	O
activity	O
and	O
VN	B:C2986386
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	O
site	I:C0449682
for	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	O
.	O

Insertions	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	O
activity	O
and	O
VN	O
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	B:C0449682
site	I:C0449682
for	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	O
.	O

Insertions	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	O
activity	O
and	O
VN	O
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	O
site	I:C0449682
for	O
infectious	B:C0021338
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	O
.	O

Insertions	O
in	O
the	O
UL3	O
-	I:C0314659
4	I:C0314659
region	I:C0314659
permitted	O
a	O
balance	O
between	O
growth	O
activity	O
and	O
VN	O
-	I:C2986386
antibody	I:C2986386
-	O
eliciting	O
capacity	O
,	O
and	O
this	O
region	O
might	O
therefore	O
be	O
an	O
appropriate	O
insertion	O
site	I:C0449682
for	O
infectious	O
bursal	I:C0021338
disease	I:C0021338
virus	I:C0021338
VP2	B:C0017337
.	O

